Drug Type Targeted protein degraders, Single-chain FV antibody fragment |
Synonyms- |
Target |
Mechanism KRAS inhibitors(GTPase KRas inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
KRAS mutation-related tumors | Preclinical | KR | 04 Apr 2023 | |
KRAS mutation-related tumors | Preclinical | KR | 04 Apr 2023 |